Statement of Principles concerning Wilson's disease No. 33 of 2015

Administered by Department of Veterans' Affairs

Legislation au F2014L01847 Not in force Legislative Instrument

Legislation content

REPATRIATION MEDICAL AUTHORITY

 

INSTRUMENT NO. 33 of 2015

 

VETERANS’ ENTITLEMENTS ACT 1986

MILITARY REHABILITATION AND COMPENSATION ACT 2004

 

EXPLANATORY NOTES FOR TABLING

 

 

  1. The Repatriation Medical Authority (the Authority), under subsection 196B(8) of the Veterans' Entitlements Act 1986 (the VEA), revokes Instrument No. 7 of 2007, determined under subsection 196B(2) of the VEA concerning Wilson's disease.
  2. The Authority is of the view that there is sound medical-scientific evidence that indicates that Wilson's disease and death from Wilson's disease can be related to particular kinds of service.  The Authority has therefore determined pursuant to subsection 196B(2) of the VEA a Statement of Principles, Instrument No. 33 of 2015 concerning Wilson's disease.  This Instrument will in effect replace the revoked Statement of Principles.
  3. The provisions of the Military Rehabilitation and Compensation Act 2004 (the MRCA) relating to claims for compensation commenced on 1 July 2004.  Claims under section 319 of the MRCA for acceptance of liability for a service injury sustained, a service disease contracted or service death on or after 1 July 2004 are determined by the Military Rehabilitation and Compensation Commission by reference to Statements of Principles issued by the Authority pursuant to the VEA.
  4. The Statement of Principles sets out the factors that must as a minimum exist, and which of those factors must be related to the following kinds of service rendered by a person:

 operational service under the VEA;

 peacekeeping service under the VEA;

 hazardous service under the VEA;

 British nuclear test defence service under the VEA;

 warlike service under the MRCA;

 non-warlike service under the MRCA,

before it can be said that a reasonable hypothesis has been raised connecting Wilson's disease or death from Wilson's disease, with the circumstances of that service.

5.             This Instrument results from an investigation notified by the Authority in the Government Notices Gazette of 2 May 2012 concerning Wilson's disease in accordance with section 196G of the VEA.  The investigation involved an examination of the sound medical-scientific evidence now available to the Authority, including the sound medical-scientific evidence it has previously considered.

6.             The contents of this Instrument are in similar terms as the revoked Instrument.  Comparing this Instrument and the revoked Instrument, the differences include:

  • revising the definition of 'Wilson's disease' in clause 3;
  • revising the definition of 'relevant service' in clause 6; and
  • specifying a date of effect for the Instrument in clause 8.

7.             Further changes to the format of the Instrument reflect the commencement of the MRCA and clarify that pursuant to subsection 196B(3A) of the VEA, the Statement of Principles has been determined for the purposes of both the VEA and the MRCA.

8.             Prior to determining this Instrument, the Authority advertised its intention to undertake an investigation in relation to Wilson's disease in the Government Notices Gazette of 2 May 2012, and circulated a copy of the notice of intention to investigate to a wide range of organisations representing veterans, service personnel and their dependants.  The Authority invited submissions from the Repatriation Commission, organisations and persons referred to in section 196E of the VEA, and any person having expertise in the field.  No submissions were received for consideration by the Authority during the investigation.

9.             This instrument is compatible with the Human Rights and Freedoms recognised or declared in the International Instruments listed in Section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011. A Statement of Compatibility with Human Rights follows.

10.         The determining of this Instrument finalises the investigation in relation to Wilson's disease as advertised in the Government Notices Gazette of 2 May 2012.

11.         A list of references relating to the above condition is available to any person or organisation referred to in subsection 196E(1)(a) to (c) of the VEA.  Any such request must be made in writing to the Repatriation Medical Authority at the following address:

The Registrar

Repatriation Medical Authority

GPO Box 1014

BRISBANE    QLD    4001

Statement of Compatibility with Human Rights

(Prepared in accordance with Part 3 of the Human Rights (Parliamentary Scrutiny) Act 2011)

 

Instrument No.:   Statement of Principles No. 33 of 2015

Kind of Injury, Disease or Death: Wilson's disease

 

This Legislative Instrument is compatible with the human rights and freedoms recognised or declared in the international instruments listed in section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.

Overview of the Legislative Instrument

1. This Legislative Instrument is determined pursuant to subsection 196B(8) of the Veterans' Entitlements Act 1986 (the VEA) for the purposes of the VEA and the Military Rehabilitation and Compensation Act 2004 (the MRCA).

2. This Legislative Instrument:-

  • facilitates claimants in making, and the Repatriation Commission in assessing, claims under the VEA and the MRCA respectively, by specifying the circumstances in which medical treatment and compensation can be extended to eligible persons who have Wilson's disease;
  • facilitates the review of such decisions by the Veterans' Review Board and the Administrative Appeals Tribunal;
  • outlines the factors which the current sound medical-scientific evidence indicates must as a minimum exist, before it can be said that a reasonable hypothesis has been raised, connecting Wilson's disease with the circumstances of eligible service rendered by a person, as set out in clause 4 of the Explanatory Notes;
  • replaces Instrument No. 7 of 2007; and
  • reflects developments in the available sound medical-scientific evidence concerning Wilson's disease which have occurred since that earlier instrument was determined. 

3. The Instrument is assessed as being a technical instrument which improves the medico-scientific quality of outcomes under the VEA and the MRCA. 

Human Rights Implications

4. This Legislative Instrument does not derogate from any human rights. It promotes the human rights of veterans, current and former Defence Force members as well as other persons such as their dependents, including:

  • the right to social security (Art 9, International Covenant on Economic, Social and Cultural Rights; Art 26, Convention on the Rights of the Child and Art 28, Convention on the Rights of Persons with Disabilities) by helping to ensure that the qualifying conditions for the benefit are 'reasonable, proportionate and transparent'[1];
  • the right to an adequate standard of living (Art 11, ICSECR; Art 27, CRC and Art 28, CRPD) by facilitating the assessment and determination of social security benefits;
  • the right to the enjoyment of the highest attainable standard of physical and mental health (Art 12, ICSECR and Art 25, CRPD), by facilitating the assessment and determination of compensation and benefits in relation to the treatment and rehabilitation of veterans and Defence Force members; and
  • the rights of persons with disabilities by facilitating the determination of claims relating to treatment and rehabilitation (Art 26, CRPD).

Conclusion

This Legislative Instrument is compatible with human rights as it does not derogate from and promotes a number of human rights.

 

Repatriation Medical Authority

 

 

 

 

 

[1] In General Comment No. 19 (The right to social security), the Committee on Economic, Social and Cultural Rights said (at paragraph 24) this to be one of the elements of ensuring accessibility to social security.

Overview

The Repatriation Medical Authority Instrument No. 33 of 2015 amends the Veterans' Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004 to address the issue of eligibility for compensation related to Wilson's disease among veterans and Defence Force members. Enacted by the Repatriation Medical Authority under the authority of the Veterans' Entitlements Act 1986, this instrument responds to the need for updated medical-scientific evidence to support claims for compensation related to Wilson's disease. By replacing the previous Instrument No. 7 of 2007 with a revised Statement of Principles, this instrument aims to facilitate more accurate assessments and approvals of claims for those affected by Wilson's disease, ensuring that the claims process is both fair and scientifically grounded. The policy objective is to provide a transparent and reasonable framework for assessing the connection between Wilson's disease and the service circumstances of affected individuals, thereby promoting their right to social security and adequate living standards.

Scope and Application

The Repatriation Medical Authority Instrument No. 33 of 2015, under the Veterans' Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004, addresses claims for compensation related to Wilson's disease for individuals who have served in various capacities including operational, peacekeeping, hazardous, and British nuclear test defence services, as well as warlike and non-warlike services. This instrument applies to veterans and Defence Force members who have contracted Wilson's disease or died from it as a result of their service. The instrument specifies the minimum factors that must exist to establish a reasonable hypothesis linking Wilson's disease to the service rendered, and it replaces a previous instrument (Instrument No. 7 of 2007) with updated definitions and a specified effective date. The Authority's determination is made pursuant to subsection 196B(2) of the VEA and is intended to facilitate the process of making and reviewing claims under both the VEA and the MRCA. The instrument does not exclude any categories of persons or entities but is instead inclusive of those who meet the specified criteria related to service and disease. The instrument's application is national in scope, affecting all relevant veterans and service personnel across Australia. The Authority's decision-making process included advertising its intention to investigate and inviting submissions from relevant parties, although no submissions were received for consideration during the investigation.

Key Provisions

The Repatriation Medical Authority (RMA) under the Veterans' Entitlements Act 1986 (VEA) has issued a new instrument, Instrument No. 33 of 2015, replacing Instrument No. 7 of 2007 concerning Wilson's disease. This instrument sets out the Statement of Principles that must be met for a claim to be considered for medical treatment and compensation related to Wilson's disease (section 8). The instrument details the types of service that must be related to the onset of Wilson's disease to establish a reasonable hypothesis connecting the disease to service circumstances (section 4). The Statement of Principles specifies the minimum factors that must exist and be related to specific types of service, such as operational, peacekeeping, and hazardous service, among others (section 4). The instrument imposes specific obligations on the parties involved, including the RMA, the Repatriation Commission, and claimants. The RMA is responsible for determining the Statement of Principles based on sound medical-scientific evidence (section 6). The Repatriation Commission must assess claims against these principles to determine eligibility for benefits. Claimants are required to provide evidence linking their Wilson's disease to their service under the outlined categories (section 4). Additionally, the instrument facilitates the review of decisions by the Veterans' Review Board and the Administrative Appeals Tribunal (section 2). There are no specific offences or penalties mentioned in the explanatory notes for this instrument. However, breaches of the requirements and obligations set out in the instrument could lead to the rejection of claims for medical treatment and compensation. The instrument promotes compliance by ensuring that claims are assessed based on clear, evidence-based criteria. The primary consequence of non-compliance would be the denial of benefits to those who do not meet the specified conditions. This approach ensures that benefits are awarded fairly and transparently to those who are genuinely eligible.

Legal classification tags

Area of Law
Veterans' Law
Health Law
Instrument
Statutory Instrument
Concepts
Definitions & Interpretation
Reporting & Disclosure Obligations
Regulatory Standards
Human Rights Law

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.